Our findings indicate that vimentin, 8-OHdG, copeptin, and endostatin would be useful in monitoring the risk of symptomatic CD progression and/or efficacy of current and newly developed drugs and vaccines in halting CD. The gene discussed is VIM; the disease is Cowden disease.